JAM
IDXG

JW Asset Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

JW Asset Management’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-282
Closed -$51K – 57
2014
Q4 		$51K Buy
+282
New +$50.2K 0.04% 49

Other funds holding IDXG

HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
LCM
Leonard Capital Management Vero Beach, Florida $5.25M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

JW Asset Management's IDXG Position: Q1 2015 in Review

JW Asset Management sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2015, closing a stake of 282 shares — an estimated $51K sold.

JW Asset Management first reported a position in IDXG in Q4 2014 and held it in 1 quarter. The position peaked at $51K in Q4 2014. 24 funds tracked by Wall St. Rank hold IDXG as of Q1 2015.

  • JW Asset Management reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • JW Asset Management sold 282 Interpace Biosciences, Inc. Common Stock shares in Q1 2015, an estimated $51K.
  • JW Asset Management first reported a position in Interpace Biosciences, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • JW Asset Management's Interpace Biosciences, Inc. Common Stock position peaked at $51K in Q4 2014.
  • 24 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2015.

Based on JW Asset Management's 13F filing for Q1 2015, filed 15 May 2015.